A review of cranberry research targeting cancer revealed positive effects of cranberries against 17 different cancers.

– GreenMedInfo Summary

Click here to read the complete article.

Abstract Title:

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents.

Abstract Source:

Antioxidants (Basel). 2016 ;5(3). Epub 2016 Aug 18. PMID: 27548236

Abstract Author(s):

Katherine M Weh, Jennifer Clarke, Laura A Kresty

Article Affiliation:

Katherine M Weh

Abstract:

Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.

Academic Cite:

Katherine M Weh, Jennifer Clarke, Laura A Kresty. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants (Basel). 2016 ;5(3). Epub 2016 Aug 18.

Pubmed-Cite:

Katherine M Weh, Jennifer Clarke, Laura A Kresty. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants (Basel). 2016 ;5(3). Epub 2016 Aug 18. PMID: 27548236

GMI-Cite:

Katherine M Weh, Jennifer Clarke, Laura A Kresty. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants (Basel). 2016 ;5(3). Epub 2016 Aug 18. PMID: 27548236

Article Published Date : Dec 31, 2015

Study Type : Review

Additional Links

Substances : Cranberry : CK(349) : AC(69)

Diseases : Cancers: All : CK(14773) : AC(4596)

Pharmacological Actions : Antiproliferative : CK(2546) : AC(1685), Apoptotic : CK(2958) : AC(2075)